Pharma
Pharmaceutical solutions
Pharmaceutical companies face increasing pressure to demonstrate the value of their therapies beyond clinical efficacy. Our health economic software enables pharma companies to build compelling value propositions, conduct comprehensive cost-effectiveness analyses, and develop evidence-based pricing strategies. Support your market access teams with robust economic models that resonate with payers and HTA bodies across different healthcare systems.
Our solutions are specifically developed for the application type of your product. We offer applications for diagnostic products such as blood tests and medical imaging, prognostic products including predictive algorithms, companion diagnostics, and therapeutics.
Diagnostics encompasses a range of technologies and tools designed to detect and monitor diseases.
Prognostics involves the use of technologies and algorithms to predict the likely course and outcome of diseases.
Companion diagnostics are specialized tests that identify patients most likely to benefit from specific treatments, enabling personalized therapies.
Treatment sequencing strategically orders therapies to maximize efficacy, reduce side effects, and improve patient outcomes.
Schedule a demo with our experts
Schedule a demo to see how Health Economic Software can improve the market uptake of your products.
Products
Designed to help you maximize the value of your diagnostic, prognostic, or companion diagnostic product.
Medip Analytics offers a cost-effectiveness evaluation service for your diagnostic, prognostic, or companion diagnostic product across any disease area.
Database and analysis of cost data from US hospitals. Search for healthcare costs based on CPT-code.
Our consultancy services are designed to assist companies with all health economic questions. We leverage our scientific expertise and extensive experience to advise you on your health economic strategy.
